WINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES
Winvest Group Limited (OTCQB: WNLV) announced that its subsidiary IQI Media has formed a strategic partnership with BioCalth International, a health supplement manufacturer. The partnership involves a content management agreement with profit-sharing incentives, including a fixed monthly retainer and percentage-based profit sharing when net revenue reaches $30,000 to $1,000,000+.
IQI Media will support BioCalth's first e-commerce launch and market their flagship calcium L-threonate product, which boasts a 95% absorption rate verified through UCLA research. Additionally, BioCalth is expanding its FDA-registered and GMP-certified California manufacturing facility to provide services to pharmaceutical and nutritional supplement companies.
Winvest Group Limited (OTCQB: WNLV) ha comunicato che la sua controllata IQI Media ha siglato una partnership strategica con BioCalth International, produttore di integratori alimentari. L'accordo prevede la gestione dei contenuti con meccanismi di condivisione degli utili, comprensivi di un compenso mensile fisso e di una quota percentuale sui profitti al raggiungimento di ricavi netti compresi tra $30.000 e $1.000.000+.
IQI Media sosterrà il primo lancio e‑commerce di BioCalth e promuoverà il loro principale prodotto a base di calcio L-treonate, che vanta un tasso di assorbimento del 95% verificato da ricerche UCLA. Inoltre, BioCalth sta ampliando il suo stabilimento californiano registrato dalla FDA e certificato GMP per offrire servizi a società farmaceutiche e produttori di integratori nutrizionali.
Winvest Group Limited (OTCQB: WNLV) anunció que su subsidiaria IQI Media ha establecido una alianza estratégica con BioCalth International, fabricante de suplementos de salud. La colaboración incluye un acuerdo de gestión de contenidos con incentivos para compartir ganancias, que contempla una retención mensual fija y un porcentaje de participación en beneficios cuando los ingresos netos alcancen entre $30,000 y $1,000,000+.
IQI Media apoyará el primer lanzamiento de comercio electrónico de BioCalth y comercializará su producto estrella de calcio L-treonato, que presenta una tasa de absorción del 95% verificada por investigaciones de UCLA. Además, BioCalth está ampliando su planta de fabricación en California, registrada ante la FDA y certificada GMP, para prestar servicios a empresas farmacéuticas y de suplementos nutricionales.
Winvest Group Limited (OTCQB: WNLV)는 자회사 IQI Media가 건강기능식품 제조사 BioCalth International와 전략적 파트너십을 체결했다고 발표했습니다. 이번 파트너십은 콘텐츠 관리 계약과 함께 이익 공유 인센티브를 포함하며, 고정 월 고정 수수료와 순수익이 $30,000에서 $1,000,000+에 도달하면 적용되는 비율 기반의 이익 분배를 포함합니다.
IQI Media는 BioCalth의 첫 전자상거래 출시에 지원을 제공하고, UCLA 연구로 검증된 흡수율 95%를 자랑하는 주력 제품 칼슘 L-트레오네이트를 마케팅할 예정입니다. 또한 BioCalth는 FDA 등록 및 GMP 인증을 받은 캘리포니아 제조 시설을 확장하여 제약 및 영양 보충제 기업에 서비스를 제공할 계획입니다.
Winvest Group Limited (OTCQB: WNLV) a annoncé que sa filiale IQI Media a conclu un partenariat stratégique avec BioCalth International, fabricant de compléments de santé. Le partenariat comprend un accord de gestion de contenu avec des incitations au partage des bénéfices, incluant une rémunération mensuelle fixe et une participation en pourcentage lorsque le chiffre d'affaires net atteint $30,000 à $1,000,000+.
IQI Media soutiendra le premier lancement e‑commerce de BioCalth et commercialisera leur produit phare, le calcium L‑thr éonate, qui affiche un taux d'absorption de 95% vérifié par des recherches de l'UCLA. De plus, BioCalth étend son site de production californien, enregistré auprès de la FDA et certifié GMP, pour proposer des services aux entreprises pharmaceutiques et de compléments nutritionnels.
Winvest Group Limited (OTCQB: WNLV) gab bekannt, dass seine Tochtergesellschaft IQI Media eine strategische Partnerschaft mit dem Nahrungsergänzungsmittel-Hersteller BioCalth International eingegangen ist. Die Partnerschaft umfasst einen Content-Management-Vertrag mit Gewinnbeteiligungsanreizen, darunter eine feste monatliche Vergütung und prozentuale Gewinnbeteiligung, sobald der Nettoumsatz zwischen $30.000 und $1.000.000+ liegt.
IQI Media wird BioCalth beim ersten E‑Commerce-Start unterstützen und ihr Flaggschiff‑Produkt Calcium L‑Threonat vermarkten, das laut UCLA‑Forschung eine 95%ige Aufnahmequote aufweist. Zudem erweitert BioCalth seine FDA-registrierte und GMP‑zertifizierte Produktionsstätte in Kalifornien, um Dienstleistungen für Pharma- und Nahrungsergänzungsunternehmen anzubieten.
- Partnership includes fixed monthly retainer plus profit-sharing incentives
- BioCalth's flagship product shows 95% absorption rate in UCLA research
- Expansion of FDA-registered and GMP-certified manufacturing facility
- New revenue stream through manufacturing services for other companies
- Revenue sharing only triggers after reaching $30,000 in net revenue
- Entering competitive direct-to-consumer supplement market with new e-commerce initiative
The two companies have entered into a content management agreement with profit-sharing incentives that they hope will lead to a long-term relationship marked by increased revenue and brand recognition for BioCalth. The agreement offers IQI Media a fixed monthly retainer as well as a percentage of the profit margin once total net revenue from conversions reaches
"BioCalth has been a prominent player in the supplement industry for over 25 years, manufacturing their patented products here in the
As part of the launch, IQI will be working to help BioCalth's products gain traction through a top-of-funnel (TOFU) strategy for social marketing that builds awareness and trust. "BioCalth has conducted extensive laboratory research at UCLA, scientifically verifying that our calcium L-threonate formula has a
In addition to kicking off direct-to-consumer sales and social marketing that targets audiences focused on self-care and bone density, BioCalth is also expanding its manufacturing pipeline at its state-of-the-art
"Initiating this new phase of expansion involves integrating sales, data analytics, and backend management," said Sophia Li, VP of Marketing at BioCalth. "It also serves as the core strategy for BioCalth's future growth, ensuring both healthy development and steady progress. We intend to bolster our standing as a GMP manufacturer that sets the bar in biotechnology production."
About IQI Media:
Headquartered in
About BioCalth:
Founded in 2000, BioCalth International Inc. is a science-based wellness company based in
About Winvest:
Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/winvest-group-subsidiary-iqi-media-partners-with-biocalth-to-drive-direct-to-consumer-sales-302535361.html
SOURCE Winvest Group Ltd
FAQ
What is the partnership between Winvest Group's IQI Media and BioCalth?
What is BioCalth's main product and its effectiveness?
How is BioCalth expanding its manufacturing capabilities?
What is IQI Media's marketing strategy for BioCalth products?
What are the revenue sharing terms in the WNLV-BioCalth partnership?
